Adaptimmune Therapeutics PLC
ADAPY- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001621227
No open-market purchases or sales by Adaptimmune Therapeutics PLC insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Adaptimmune Therapeutics PLC changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 1 | 0 | −1 |
| Shares | 3.66K | 0 | −3.66K (−100.0%) |
| Value | $72 | $0 | −$72 (−100.0%) |
New holders (0)
Institutions that held Adaptimmune Therapeutics PLC at the end of Q2 2026 but not at the end of Q1 2026.
None.
Sold out (1)
Institutions that held Adaptimmune Therapeutics PLC at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Rhumbline Advisers | 3,661 | $72 |